PharmaShots | Incisive News in 3 Shots

Subscribe Now

granted

AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Priority Review for Chronic Kidney Disease

AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Priority Review for Chronic Kidney Disease

January 6, 2021

Roche Reports the US FDA Acceptance of sBLA and Granted Priority Review for Tecentriq (atezolizumab) as 1L Monotherapy for Advanced Non-Small Cell Lung Cancer

Roche Reports the US FDA Acceptance of sBLA and Granted Priority Review for Tecentriq (atezolizumab) as 1L Monotherapy for Advance...

February 19, 2020

AstraZeneca Reports the US FDA Acceptance of sBLA and Granted Priority Review for Imfinzi (durvalumab) to Treat Patients with Extensive-Stage Small Cell Lung Cancer

AstraZeneca Reports the US FDA Acceptance of sBLA and Granted Priority Review for Imfinzi (durvalumab) to Treat Patients with Exte...

November 29, 2019

Zogenix Reports the US FDA Acceptance of NDA and Granted Priority Review for Fintepla (fenfluramine) to Treat Dravet Syndrome

Zogenix Reports the US FDA Acceptance of NDA and Granted Priority Review for Fintepla (fenfluramine) to Treat Dravet Syndrome

November 26, 2019

Roche Reports the US FDA's Acceptance of NDA for Risdiplam and Granted Priority Review to Treat Spinal Muscular Atrophy

Roche Reports the US FDA's Acceptance of NDA for Risdiplam and Granted Priority Review to Treat Spinal Muscular Atrophy

November 25, 2019

Shire Receives EU's MAA for VEYVONDI for the Treatment of von Willebrand disease in adults

Shire Receives EU's MAA for VEYVONDI for the Treatment of von Willebrand disease in adults

September 12, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us